Physician profile
Brian R Davis
NPI 1801043724
$4,768.58
in general payments reported to CMS, 2019-2025
13 companies · $1,233 in 2025
The $1,233 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,203 · 2020: $13.48 · 2021: $1,828 · 2022: $263 · 2023: $205 · 2024: $22.49 · 2025: $1,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $965 · Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $965.40 |
| Food and Beverage | $495.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,834.50 | 2019-2025 | Apollo Esg Nxt System, Overstitch Endoscopic Suturing System |
| Intuitive Surgical, INC. | $1,766.57 | 2019-2022 | |
| Enterra Medical, INC. | $282.88 | 2022-2023 | |
| Davol INC. | $232.50 | 2019 | |
| Becton, Dickinson and Company | $133.86 | 2019 | |
| Avanos Medical | $120.18 | 2019 | |
| Medtronic USA, INC. | $117.13 | 2019 | |
| Endogastric Solutions, INC | $112.00 | 2021 | |
| Medtronic, INC. | $53.71 | 2021-2022 | |
| Abbott Laboratories | $44.82 | 2023-2024 | Assurity, Confirm Rx |
| Ambu INC. | $31.82 | 2021 | |
| Tela Bio, INC. | $25.13 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.